Market Watch: Amprius Technologies Inc (AMPX)’s Noteworthy Drop, Closing at 2.80

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

As of close of business last night, Amprius Technologies Inc’s stock clocked out at $2.80, down -6.04% from its previous closing price of $2.98. In other words, the price has decreased by -$6.04 from its previous closing price. On the day, 6.62 million shares were traded. AMPX stock price reached its highest trading level at $3.36 during the session, while it also had its lowest trading level at $2.52.

Ratios:

To gain a deeper understanding of AMPX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.93 and its Current Ratio is at 4.05. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.53.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on January 11, 2024, initiated with a Buy rating and assigned the stock a target price of $10.

On December 05, 2023, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $10.Alliance Global Partners initiated its Buy rating on December 05, 2023, with a $10 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 21 ’24 when Sun Kang sold 33,779 shares for $1.96 per share. The transaction valued at 66,362 led to the insider holds 1,316,974 shares of the business.

Bornstein Jonathan sold 133,536 shares of AMPX for $256,883 on Nov 20 ’24. The President of Amprius Lab now owns 1,039,187 shares after completing the transaction at $1.92 per share. On Nov 21 ’24, another insider, Bornstein Jonathan, who serves as the President of Amprius Lab of the company, sold 18,170 shares for $1.96 each. As a result, the insider received 35,697 and left with 454,131 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPX now has a Market Capitalization of 309609984 and an Enterprise Value of 298564608. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.42 while its Price-to-Book (P/B) ratio in mrq is 4.64. Its current Enterprise Value per Revenue stands at 17.08 whereas that against EBITDA is -7.31.

Stock Price History:

Over the past 52 weeks, AMPX has reached a high of $5.29, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 47.98%, while the 200-Day Moving Average is calculated to be 80.84%.

Shares Statistics:

It appears that AMPX traded 2.96M shares on average per day over the past three months and 5210160 shares per day over the past ten days. A total of 107.98M shares are outstanding, with a floating share count of 76.14M. Insiders hold about 31.14% of the company’s shares, while institutions hold 7.47% stake in the company. Shares short for AMPX as of 1734048000 were 3663338 with a Short Ratio of 1.24, compared to 1731628800 on 3337874. Therefore, it implies a Short% of Shares Outstanding of 3663338 and a Short% of Float of 9.98.

Most Popular